Classic's positive gold processing data may point to early revenues

|

Published 14-JUL-2020 13:43 P.M.

|

3 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

Western Australian gold exploration and development company Classic Minerals Limited (ASX:CLZ) has reported promising results from a preliminary metallurgical test work program on samples collected from drilling at Kat Gap, part of the group’s Forrestania Gold Project (FGP).

The test work has been conducted on fresh mineral samples from the Kat Gap program, the area which was the subject of outstanding high-grade drilling results released just last week.

These included 4 metres grading 76.7 g/t gold from 79 metres.

The tests completed covered both conventional gravity and leach testing on the samples provided.

The results have been particularly encouraging as the material tested indicated that the majority of the gold could be recovered by traditional gravity separation techniques and with the mineralisation located from near-surface, this has the potential to provide a low processing cost option for the material.

Near-surface high-grade mineralisation has been a feature of drill testing completed at Kat Gap, and the company is in the process of completing further drilling which could well identify similar styles and grades of mineralisation.

These results take on even more importance given that management is working towards expanding the resource and conducting open pit optimisation studies that could see the commencement of early-stage production.

Classic has a solid base to build on at FGP with a global mineral resource of 8.2 million tonnes at 1.5 g/t gold for 404,000 ounces of gold, with a recent scoping study suggesting both the technical and financial viability of the project.

It could be argued that the inferred value of this resource, combined with the prospect of exploration upside and the potential to move to relatively near-term production isn’t captured in Classic’s market capitalisation of $28 million.

Conventional process delivers 95% recovery - early revenues

The conventional gravity separation process has delivered up to 75% gold recovery from the oxide samples with the conventional cyanide leach process providing 95% - 96% recovery from both fresh and oxide samples.

These results are extremely positive, and the next stage of testing is focusing on variability across the mineralisation and firming up the process options to consistently deliver the indicated recoveries.

The preliminary results indicate that Classic has the potential for early revenue generation through either toll treatment or self-processing of the material from Kat Gap.

The toll treating provides rapid cash flow while the onsite processing provides greater profitability as Classic can control all mining and processing costs.

Highlighting the combined benefits of resource expansion and promising processing information, chief executive Dean Goodwin said, ‘’After conducting detailed research we are fortunate to have found that the metallurgical results confirm that the ore, when processed using traditional gravity and leach processes provide an outstanding gold recovery.

‘’The recent results offer great hope that there is the possibility of gold deposits to augment and further enhance the gold resources already determined at Kat Gap.

‘’We will be working on extending the resource with more infill drilling and then expanding the resource with extensional drilling along strike as well as in the granite.’’



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X